Ashida Kayoko, Katsura Toshiya, Saito Hideyuki, Inui Ken-ichi
Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.
Pharm Res. 2004 Jun;21(6):969-75. doi: 10.1023/b:pham.0000029285.45101.ee.
To examine the effect of thyroid hormone status on PEPT1 in vivo, the activity and expression of PEPT1 in the small intestine were examined in euthyroid and hyperthyroid rats.
Hyperthyroidism was induced by treating rats with L-thyroxine (12 mg/L) in the drinking water for 21 days. Transport activity was measured by everted small intestinal preparations and in situ intestinal loop technique. Expressions of PEPT1 mRNA and protein were evaluated by competitive polymerase chain reaction and Western blotting, respectively.
The uptake of [14C]glycylsarcosine by everted small intestinal preparations was significantly decreased in hyperthyroid rats, whereas that of methyl-alpha-D-[14C(U)]-glucopyranoside was not altered. Kinetic analysis showed that the Vmax value for [14C]glycylsarcosine uptake was significantly decreased in hyperthyroid rats, whereas the Km value was not affected. The mean portal vein concentrations after intrajejunal administration of [14C]glycylsarcosine were also decreased in hyperthyroid rats. Moreover, hyperthyroidism caused a significant decrease in the expression of PEPT1 mRNA in the small intestine, whereas the expression of Na+/glucose cotransporter (SGLT1) mRNA was not changed. The level of PEPT1 protein was also decreased in the small intestine of hyperthyroid rats.
These results indicate that in hyperthyroid rats, the activity and expression of PEPT1 were decreased in the small intestine.
为了研究甲状腺激素状态对体内肽转运体1(PEPT1)的影响,我们检测了甲状腺功能正常和甲状腺功能亢进大鼠小肠中PEPT1的活性和表达。
通过在饮水中给予大鼠L-甲状腺素(12 mg/L)21天来诱导甲状腺功能亢进。采用外翻小肠制备法和原位肠袢技术测量转运活性。分别通过竞争性聚合酶链反应和蛋白质免疫印迹法评估PEPT1 mRNA和蛋白的表达。
甲状腺功能亢进大鼠外翻小肠制备物对[14C]甘氨酰肌氨酸的摄取显著降低,而对甲基-α-D-[14C(U)]-吡喃葡萄糖苷的摄取未改变。动力学分析表明,甲状腺功能亢进大鼠对[14C]甘氨酰肌氨酸摄取的Vmax值显著降低,而Km值不受影响。甲状腺功能亢进大鼠空肠内给予[14C]甘氨酰肌氨酸后门静脉的平均浓度也降低。此外,甲状腺功能亢进导致小肠中PEPT1 mRNA的表达显著降低,而钠/葡萄糖共转运体(SGLT1)mRNA的表达未改变。甲状腺功能亢进大鼠小肠中PEPT1蛋白水平也降低。
这些结果表明,在甲状腺功能亢进大鼠中,小肠中PEPT1的活性和表达降低。